Title: Full Text of HB1720
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HB1720 ILGA.GOV HB1720 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB1720 Introduced 1/28/2025, by Rep. Amy Elik SYNOPSIS AS INTRODUCED: New Act    Creates the Retail Sale of Tianeptine Prohibition Act. Provides that beginning January 1, 2026, no person shall sell, offer to sell, or distribute in the State any product containing tianeptine. Provides that the Act does not apply to any product containing tianeptine that is lawfully dispensed or prescribed by a pharmacist or a health care professional. Provides that a violation is a business offense, punishable by a minimum fine of $1,500 for each violation. Defines "health care professional". Effective January 1, 2026.LRB104 03276 RLC 13298 b  A BILL FOR HB1720LRB104 03276 RLC 13298 b1    AN ACT concerning criminal law. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 1. Short title. This Act may be cited as the Retail 5Sale of Tianeptine Prohibition Act. 6    Section 5. Retail sale of tianeptine products. 7    (a) Beginning January 1, 2026, no person shall sell, offer 8to sell, or distribute in the State any product containing 9tianeptine.10    (b) This Act does not apply to any product containing 11tianeptine that is lawfully dispensed or prescribed by a 12pharmacist or a health care professional. In this subsection 13(b), "health care professional" means any person who treats 14human ailments and is subject to licensure or regulation by 15this State, including students and residents. 16    Section 10. Sentence. A violation of Section 5 is a 17business offense, punishable by a minimum fine of $1,500 for 18each violation. 19    Section 99. Effective date. This Act takes effect January 201, 2026.


================================================================================

Raw Text:
Full Text of HB1720 ILGA.GOV HB1720 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB1720 Introduced 1/28/2025, by Rep. Amy Elik SYNOPSIS AS INTRODUCED: New Act    Creates the Retail Sale of Tianeptine Prohibition Act. Provides that beginning January 1, 2026, no person shall sell, offer to sell, or distribute in the State any product containing tianeptine. Provides that the Act does not apply to any product containing tianeptine that is lawfully dispensed or prescribed by a pharmacist or a health care professional. Provides that a violation is a business offense, punishable by a minimum fine of $1,500 for each violation. Defines "health care professional". Effective January 1, 2026.LRB104 03276 RLC 13298 b  A BILL FOR HB1720LRB104 03276 RLC 13298 b1    AN ACT concerning criminal law. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 1. Short title. This Act may be cited as the Retail 5Sale of Tianeptine Prohibition Act. 6    Section 5. Retail sale of tianeptine products. 7    (a) Beginning January 1, 2026, no person shall sell, offer 8to sell, or distribute in the State any product containing 9tianeptine.10    (b) This Act does not apply to any product containing 11tianeptine that is lawfully dispensed or prescribed by a 12pharmacist or a health care professional. In this subsection 13(b), "health care professional" means any person who treats 14human ailments and is subject to licensure or regulation by 15this State, including students and residents. 16    Section 10. Sentence. A violation of Section 5 is a 17business offense, punishable by a minimum fine of $1,500 for 18each violation. 19    Section 99. Effective date. This Act takes effect January 201, 2026.